USFDA Guidance: Reporting Amount of Listed Drugs and Biological Product and Key Information and Facilitating Understanding in Informed Consent Guidance
EMA: QRD updation and Product-Information Templates Updation
UK MHRA Guidance: Navigating on Applying for a Licence to Market a Medicine
South Africe SAPHRA: Guidelines For Medicine Recalls – Withdrawals And Rapid Alerts
TGA MD Guidance: Medical Device Labelling Obligations
USFDA Guidance: Q&A-Charging for Investigational Drugs Under an IND - What You Need to Know
EMA Guidance: Electronic Submission of Information for Investigational Medicinal Products in XEVMPD
USFDA Guidance: Use of Data Monitoring Committees in Clinical Trials
USFDA CMC Guidance: Advanced Manufacturing Technologies Designation Program
Swissmedic Guidance: Navigating Variations, Product Information, and Electronic ICSRs through PV Gateway
USFDA Guidance: "Understanding the USFDA Notification Process for Discontinuance or Interruption in Manufacturing of Pharmaceutical Products"